CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, is featured in PharmaVOICE’s June 2017 edition for feature article “Choosing the Right EDC/DM Partner: Critical Considerations for Small to Medium Sized Life Sciences Organizations”.
ARTICLE EXCERPT:
Whether you are a start-up pharmaceutical or biotech company, a medical devices innovator, or an established organization you want to be equipped with the best possible solution for your study.
For small- to medium-sized organizations finding an eClinical partner that is not only competitive but the correct fit is crucial to both program and organizational success. Successful organizations all have one thing in common: they consider all elements of a trial, including vendor selection, from a strategic perspective. Asking the right questions will help you make the most informed decision.
